Cargando…
Connexin 43: A Target for the Treatment of Inflammation in Secondary Complications of the Kidney and Eye in Diabetes
Of increasing prevalence, diabetes is characterised by elevated blood glucose and chronic inflammation that precedes the onset of multiple secondary complications, including those of the kidney and the eye. As the leading cause of end stage renal disease and blindness in the working population, more...
Autores principales: | Cliff, Chelsy L., Williams, Bethany M., Chadjichristos, Christos E., Mouritzen, Ulrik, Squires, Paul E., Hills, Claire E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776095/ https://www.ncbi.nlm.nih.gov/pubmed/35054783 http://dx.doi.org/10.3390/ijms23020600 |
Ejemplares similares
-
Connexin-43 hemichannels orchestrate NOD-like receptor protein-3 (NLRP3) inflammasome activation and sterile inflammation in tubular injury
por: Roger, Elena, et al.
Publicado: (2023) -
Blocking connexin 43 hemichannel‐mediated ATP release reduces communication within and between tubular epithelial cells and medullary fibroblasts in a model of diabetic nephropathy
por: Williams, Bethany M., et al.
Publicado: (2022) -
Collagen I Modifies Connexin-43 Hemichannel Activity via Integrin α2β1 Binding in TGFβ1-Evoked Renal Tubular Epithelial Cells
por: Potter, Joe A., et al.
Publicado: (2021) -
Blocking Connexin-43 mediated hemichannel activity protects against early tubular injury in experimental chronic kidney disease
por: Price, Gareth W., et al.
Publicado: (2020) -
The Role of Connexin 43 in Renal Disease: Insights from In Vivo Models of Experimental Nephropathy
por: Roger, Elena, et al.
Publicado: (2022)